ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EPOC Epocrates, Inc. (MM)

11.73
0.00 (0.00%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Epocrates, Inc. (MM) NASDAQ:EPOC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.73 0 01:00:00

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, I...

17/01/2013 11:14pm

PR Newswire (US)


Epocrates, Inc. (MM) (NASDAQ:EPOC)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Epocrates, Inc. (MM) Charts.
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, Inc. in Connection with the Sale of the Company to athenahealth, Inc.

NEW YORK, Jan. 17, 2013 /PRNewswire/ -- Levi & Korsinsky notifies investors of Epocrates, Inc. ("Epocrates" or the "Company") (NasdaqGS: EPOC) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to athenahealth, Inc. (Nasdaq: ATHN). A complaint was filed in California state court.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

Click here to learn how to join the action: http://zlk.9nl.com/epocrates-epoc/, or call toll free 1-877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Epocrates shareholders will receive $11.75 for each share of Epocrates stock they own. The transaction has a total approximate value of $293 million. The claims concern whether the Epocrates Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before entering into this transaction and whether athenahealth, Inc. is underpaying for Epocrates, thus unlawfully harming Epocrates stockholders. In particular, at least one analyst set a price target for Epocrates stock at $15.00 per share.

If you own common stock in Epocrates and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or http://zlk.9nl.com/epocrates-epoc/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington, D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors.  For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Copyright 2013 PR Newswire

1 Year Epocrates, Inc. (MM) Chart

1 Year Epocrates, Inc. (MM) Chart

1 Month Epocrates, Inc. (MM) Chart

1 Month Epocrates, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock